TB-500 (Thymosin Beta-4) 10mg Research Profile

Current catalog abstract

Documented material overview

TB-500 (Thymosin Beta-4) is a synthetic peptide composed of 43 amino acids and modeled after the biologically active region of the naturally occurring thymic protein Thymosin Beta-4 (Tβ4). Within laboratory and preclinical research environments, this peptide has attracted substantial interest due to its observed role in cellular migration, tissue organization, angiogenic signaling pathways, and structural remodeling following stress or injury in experimental models. Research investigating Thymosin Beta-4 and its synthetic analogue TB-500 has primarily focused on mechanisms related to cytoprotection, actin regulation, wound repair signaling, inflammation modulation, and oxidative stress reduction across multiple tissue systems. These processes are foundational to regenerative biology, making TB-500 a peptide of interest in experimental models related to musculoskeletal integrity, vascular development, neurological tissue response, and cardiac cellular resilience. TB-500 supplied for research applications is manufactured as a high purity, LPS-free peptide and is classified as an endotoxin-free peptide, ensuring minimal interference in sensitive experimental systems. Each batch is produced under stringent quality controls and is research peptides endotoxin tested, supporting reproducibility and reliability in in-vitro and preclinical study designs. This material is intended strictly for laboratory research and scientific investigation only. TB-500 is not intended for human or animal use, and no information herein should be interpreted as relating to therapeutic applications, clinical outcomes, or direct biological benefit outside of controlled research settings.